Cyclerion Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CYCN on Nasdaq
Industry
Pharmaceutical Preparations
Location
301 Binney Street, Cambridge, MA

Insiders trading volume in the past year

Cyclerion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter M. Hecht Director, 10%+ Owner $1.28M Jan 1, 2024
Regina M. Graul President and Chief Executive Officer, Director $341K Aug 5, 2024
Terrance Mcguire Director $143K Nov 30, 2023
Errol B. Desouza Director $102K Nov 30, 2023
Michael J. Higgins Director $73.5K Nov 30, 2023
Steven Hyman Director $67.9K Nov 30, 2023
Dina Katabi Director $67.9K Nov 30, 2023
Rhonda Chicko Chief Financial Officer $61.00 Mar 4, 2024
Slate Path Capital LP 10%+ Owner $0 -$555K -100% Nov 21, 2024
Kevin Churchwell Director Jun 24, 2021
Ole Isacson Director Jun 14, 2022
Cheryl Gault Chief Operating Officer Jan 20, 2022
George H. Conrades Director Jun 14, 2022
Stephanie Lovell Director Jun 14, 2022
Michael Mendelsohn Director Jun 14, 2022
Anjeza Gjino Chief Financial Officer Jan 20, 2022
Marsha Fanucci Director Jun 14, 2022
Andreas Busch Chief Scientific Officer Jan 20, 2022

Recent Insider Transactions by Companies or Individuals for Cyclerion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.